Previous Page  17 / 20 Next Page
Information
Show Menu
Previous Page 17 / 20 Next Page
Page Background

Volume 5, Issue 3(Suppl)

Biochem Anal Biochem 2016

ISSN: 2161-1009, Biochem an open access journal

Page 58

Biochemistry 2016

October 10-12, 2016

conferenceseries

.com

Biochemistry

October 10-12, 2016 Kuala Lumpur, Malaysia

International Conference on

Hereditary spastic paraplegias: Identification of a novel SPG57 variant affecting TFG oligomerization and

description of HSP subtypes in Sudan

Ashraf Yahia Osman Mohamed

National University-Sudan, Sudan

H

ereditary spastic paraplegias (HSP) are the second most common type of motor neuron disease recognized worldwide. HSP can

be pure or complex according to the absence or presence of additional neurological and non-neurological manifestations. There

are more than 67 known HSP genes with different patterns of inheritance. Autosomal dominant HSP forms are the most frequent

in western populations while recessive HSP predominates in highly consanguineous communities. Our goals were to estimate the

relative frequencies of known HSP genes in Sudanese families with the disease and perform genotype-phenotype correlation to

extend the clinical spectrum associated with HSP genes. We have used next generation sequencing to screen 74 HSP-related genes in

23 consanguineous families from Sudan and candidate gene sequencing in two other families (total of 25 families). We established

a genetic diagnosis in six families with autosomal recessive

HSP (SPG11

in three families and

TFG/SPG57

,

SACS

, and

ALS2

in one

family each). An autosomal dominant HSP (ATL1/SPG3A) was also identified in one additional family. Six out of seven identified

variants were novel. The

TFG/SPG57

variant (

p.(Arg22Trp)

in the PB1 domain) is the second SPG57 HSP variant to be identified

worldwide, and we demonstrated its impact on TFG oligomerization

in vitro

. There were no patients with visual impairment as

observed in a previously reported SPG57 family (p. (Arg106Cys) in coiled coil domain), suggesting unique contributions of the PB1

and coiled coil domains in TFG complex formation/function and a possible phenotype correlation to variant location. Some families

manifested marked phenotypic variations implying the possibility of modifier factors complicated by high inbreeding. In conclusion,

we identified the first Sudanese families carrying novel variants in 6 HSP genes. The difficulty to reach a genetic diagnosis in the

majority of studied families suggests the possibility of new genes, unusual models of inheritance or noncoding variations underlying

spinocerebellar degeneration.

kambalawy@hotmail.com

In vitro

interaction of soluble and amyloid form of serum amyloid protein with amyloid P component to

hepta 1-6 cells

Asokan Chinnasamy

and

Shagari A B

Sokoto State University, Nigeria

H

epta 1-6 cell binding study is important in relation to the activity of membrane proteins, because losing the activity of such

systems will ultimately lead to malfunction or death of the cell. The interactions of SerumAmyloid A (SAA) and SerumAmyloid

A protofibrils with Serum Amyloid P component [SAP (CaCl

2

)] to hepta 1-6 cells of the mouse are dealt with in detail to study the

binding of SAA protofibrils in various conditions. The induced fluorescence, circular dichroism, FACScan and MTT assay results

have shown the SAA and SAA fibrils binding with SAP (CaCl

2

) 0.12-1.2 nM and cell toxicity with the hepta 1-6 cells. Specifically,

interaction of serum amyloid A fibrils with a cell surface binding site/receptor might alter the local environment to cause cellular

dysfunction and to be more favorable for amyloid formation. Already RAGE (receptor for advanced glycation endproducts) a

polyvalent receptor in the immunoglobulin super family has been implicated in binding with the isoform of SAA (SAA1.1) which has

the highest fibirillogenic property. In the present study, SAA fibrils have more binding and cell cytotoxicity than SAA protein and has

protective role with SAP (CaCl

2

).

asokan_74@hotmail.com

Biochem Anal Biochem 2016, 5:3(Suppl)

http://dx.doi.org/10.4172/2161-1009.S1.006